The International Journal of Cardiovascular Imaging

, Volume 27, Issue 8, pp 1115–1122

Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies

  • Alec Vahanian
  • Bernard Iung
  • Dominique Himbert
  • Patrick Nataf
Original Paper


Valvular heart disease remains frequent in industrialised countries since the decrease in frequency of rheumatic heart diseases has been accompanied by an increase in degenerative valve diseases. The prevalence of valvular disease increases sharply with age, as a consequence of the predominance of degenerative valvular diseases. Aortic stenosis and mitral regurgitation are the two most frequent diseases among patients referred because of valvular disease in Europe. The burden of heart valve disease in the elderly has an important impact on patient management, given the frequency of comorbidity and the increase in the risk of interventions. The changes in demographics explain why new procedures, such as transcatheter aortic valve implantation and percutaneous mitral valve repair, are potentially attractive in patients with high risk or even contraindications for surgery.


Valve disease Aortic stenosis Mitral regurgitation Valve surgery Transcatheter aortic valve implantation 


  1. 1.
    Soler-Soler J, Galve E (2000) Worldwide perspective of valve disease. Heart 83:721–725PubMedCrossRefGoogle Scholar
  2. 2.
    Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685–694PubMedCrossRefGoogle Scholar
  3. 3.
    Vahanian A, Palacios IF (2004) Percutaneous approaches to valvular disease. Circulation 109:1572–1579PubMedCrossRefGoogle Scholar
  4. 4.
    Marijon E, Ou P, Celermajer DS et al (2007) Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 357:470–476PubMedCrossRefGoogle Scholar
  5. 5.
    Nkomo VT, Gardin JM, Skelton TN et al (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011PubMedCrossRefGoogle Scholar
  6. 6.
    Iung B, Baron G, Butchart EG et al (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J 24:1231–1243PubMedCrossRefGoogle Scholar
  7. 7.
    Iung B, Baron G, Tornos P et al (2007) Valvular heart disease in the community: a European experience. Curr Probl Cardiol 32:609–661PubMedCrossRefGoogle Scholar
  8. 8.
    Stewart BF, Siscovick D, Lind BK et al (1997) Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J Am Coll Cardiol 29:630–634PubMedCrossRefGoogle Scholar
  9. 9.
    Lindroos M, Kupari M, Heikkilä J, Tilvis R (1993) Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21:1220–1225PubMedCrossRefGoogle Scholar
  10. 10.
    Vahanian A, Baumgartner H, Bax J et al (2007) Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 28:230–268PubMedGoogle Scholar
  11. 11.
    Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52:e1–e142PubMedCrossRefGoogle Scholar
  12. 12.
    Michelena HI, Desjardins VA, Avierinos J-F et al (2008) Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 117:2776–2784PubMedCrossRefGoogle Scholar
  13. 13.
    Roberts WC, Ko JM (2005) Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111:920–925PubMedCrossRefGoogle Scholar
  14. 14.
    Singh JP, Evans JC, Levy D et al (1999) Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83:897–902PubMedCrossRefGoogle Scholar
  15. 15.
    Reid CL, Anton-Culver H, Yunis C, Gardin JM (2007) Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol 99:830–834PubMedCrossRefGoogle Scholar
  16. 16.
    Freed LA, Levy D, Levine RA et al (1999) Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 341:1–7PubMedCrossRefGoogle Scholar
  17. 17.
    Desjardins VA, Enriquez-Sarano M, Tajik AJ et al (1996) Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med 100:149–156PubMedCrossRefGoogle Scholar
  18. 18.
    Bursi F, Enriquez-Sarano M, Nkomo VT et al (2005) Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111:295–301PubMedCrossRefGoogle Scholar
  19. 19.
    Grigioni F, Enriquez-Sarano M, Zehr KJ et al (2001) Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103:1759–1764PubMedGoogle Scholar
  20. 20.
    The Society of Thoracic Surgeons (2010). Adult Cardiac Surgery Database,Executive Summary, 10 Years STS Report—Period Ending 12/31/2009 [online],
  21. 21.
    Brown JM, O’Brien SM, Wu C et al (2009) Isolated aortic valve replacement in North America comprising 108, 687 patients in 10 years: changes in risks, valve types, and outcomes in the society of thoracic surgeons national database. J Thorac Cardiovasc Surg 137:82–90PubMedCrossRefGoogle Scholar
  22. 22.
    Gammie JS, Sheng S, Griffith BP et al (2009) Trends in mitral valve surgery in the United States: results from the society of thoracic surgeons adult cardiac surgery database. Ann Thorac Surg 87:1431–1437PubMedCrossRefGoogle Scholar
  23. 23.
    Iung B, Cachier A, Baron G et al (2005) Decision making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26:2714–2720PubMedCrossRefGoogle Scholar
  24. 24.
    Mirabel M, Iung B, Baron G, et al. (2007) What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J;(in press, published on-line 9 March 2007, doi:10.1093/eurheartj/ehm001)
  25. 25.
    Bach DS, Awais M, Gurm HS, Kohnstamm S (2009) Failure of guideline adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol 54:860–865PubMedCrossRefGoogle Scholar
  26. 26.
    Toledano K, Rudski LG, Huynh T et al (2007) Mitral regurgitation: determinants of referral for cardiac surgery by Canadian cardiologists. Can J Cardiol 23:209–214PubMedCrossRefGoogle Scholar
  27. 27.
    Roques F, Nashef SA, Michel P, et al. (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816–822; discussion 822–813Google Scholar
  28. 28.
    Edwards FH, Peterson ED, Coombs LP et al (2001) Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37:885–892PubMedCrossRefGoogle Scholar
  29. 29.
    Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRefGoogle Scholar
  30. 30.
    Lee SJ, Lindquist K, Segal MR et al (2006) Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295:801–808PubMedCrossRefGoogle Scholar
  31. 31.
    Vahanian A, Alfieri O, Al-Attar N et al (2008) Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 29:1463–1470PubMedCrossRefGoogle Scholar
  32. 32.
    Rodés-Cabau J, Webb JG, Cheung A et al (2010) Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 55:1080–1090PubMedCrossRefGoogle Scholar
  33. 33.
    Thomas M, Schymik G, Walther T et al (2010) Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122:62–69PubMedCrossRefGoogle Scholar
  34. 34.
    Leon MB, Smith CR, Mack M et al. for the PARTNER trial investigators (2010) Transcatheter Aortic-valve implantation for Aortic Stenosis in patients who cannot undergo surgery. N Eng J Med 363:1597–1607Google Scholar
  35. 35.
    Himbert D, Descoutures F, Al-Attar N et al (2009) Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 54:303–311PubMedCrossRefGoogle Scholar
  36. 36.
    Feldman T, Kar S, Rinaldi M, et al. for the EVEREST Investigators (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 54:686–694Google Scholar
  37. 37.
    Tamburino C, Ussia GP, Maisano F et al (2010) Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 31:1382–1389PubMedCrossRefGoogle Scholar
  38. 38.
    Franzen O, Baldus S, Rudolph V et al (2010) Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 31:1373–1381PubMedCrossRefGoogle Scholar
  39. 39.
    Vahanian A, Iung B (2010) ‘Edge to edge’ percutaneous mitral valve repair in mitral regurgitation: it can be done but should it be done? Eur Heart J 31:1301–1304PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2011

Authors and Affiliations

  • Alec Vahanian
    • 1
  • Bernard Iung
    • 1
  • Dominique Himbert
    • 1
  • Patrick Nataf
    • 2
  1. 1.Cardiology DepartmentHôpital BichâtParisFrance
  2. 2.Cardiac Surgery DepartmentHôpital BichâtParisFrance

Personalised recommendations